Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 2:299:198423.
doi: 10.1016/j.virusres.2021.198423. Epub 2021 Apr 13.

Quantifying the effect of trypsin and elastase on in vitro SARS-CoV infections

Thalia Rodriguez  1 , Hana M Dobrovolny  2
Affiliations

Quantifying the effect of trypsin and elastase on in vitro SARS-CoV infections

Thalia Rodriguez et al. Virus Res. .

Abstract

The SARS coronavirus (SARS-CoV) has the potential to cause serious disease that can spread rapidly around the world. Much of our understanding of SARS-CoV pathogenesis comes from in vitro experiments. Unfortunately, in vitro experiments cannot replicate all the complexity of the in vivo infection. For example, proteases in the respiratory tract cleave the SARS-CoV surface protein to facilitate viral entry, but these proteases are not present in vitro. Unfortunately, proteases might also have an effect on other parts of the replication cycle. Here, we use mathematical modeling to estimate parameters characterizing viral replication for SARS-CoV in the presence of trypsin or elastase, and in the absence of either. In addition to increasing the infection rate, the addition of trypsin and elastase causes lengthening of the eclipse phase duration and the infectious cell lifespan.

Keywords: Coronavirus; In vitro infections; Mathematical model; Parameter estimation; Protease.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Schematic of the mathematical model. Target cells are infected by virus at rate β. They remain in the eclipse phase for a time τE and actively release virus at rate p for a time τI.
Fig. 2
Fig. 2
Fits for SARS-CoV data in the presence of trypsin (left) or elastase (center), and in the absence of either (right).
Fig. 3
Fig. 3
Parameter distributions for SARS-CoV infecting VeroE6 cells in the presence of elastase, trypsin or absence of both. Parameters are: infection rate (top left), viral production rate (top right), eclipse phase duration (center left), infectious cell life span (center right), and infecting time (bottom).
See this image and copyright information in PMC

References

    1. Ami Y., Nagata N., Shirato K., Watanabe R., Iwata N., Nakagaki K., Fukushi S., Saijo M., Morikawa S., Taguchi F. Co-infection of respiratory bacterium with severe acute respiratory syndrome coronavirus induces an exacerbated pneumonia in mice. Microbiol. Immunol. 2008;52(2):118–127. doi: 10.1111/j.1348-0421.2008.00011.x. - DOI - PMC - PubMed
    1. Arias C., Romero P., Alvarez V., Lopez S. Trypsin activation pathway of rotavirus infectivity. J. Virol. 1996;70(9):5832–5839. - PMC - PubMed
    1. Beggs N.F., Dobrovolny H.M. Determining drug efficacy parameters for mathematical models of influenza. J. Biol. Dyn. 2015;9(S1):332–346. doi: 10.1080/17513758.2015.1052764. - DOI - PubMed
    1. Belouzard S., Chu V.C., Whittaker G.R. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc. Natl. Acad. Sci. USA. 2009;106(14):5871–5876. - PMC - PubMed
    1. Belouzard S., Madu I., Whittaker G.R. Elastase-mediated activation of the severe acute respiratory syndrome coronavirus spike protein at discrete sites within the S2 domain. J. Biol. Chem. 2010;285(30):22758–22763. - PMC - PubMed

LinkOut - more resources